What are Amphastar Pharmaceuticals's profit margins?

Amphastar Pharmaceuticals (AMPH) runs a 47.3% gross margin and a 16.2% operating margin, with a 11.0% net margin.

Where do Amphastar Pharmaceuticals's ratios come from?

Every ratio is computed from Amphastar Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Amphastar Pharmaceuticals AMPH Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	47.3%-3.2pp	49.5%-1.6pp	49.4%-3.6pp	49.9%-4.8pp	50.5%-3.8pp
Operating margin	16.2%-10.4pp	19.5%-8.6pp	20.7%-8.9pp	25.1%-7.1pp	26.6%-4.6pp
Net margin	11%-8.4pp	13.6%-8.2pp	15.4%-6.4pp	18.6%-4.7pp	19.4%-3.5pp
EBITDA margin	24.2%-9.8pp	27.4%-7.9pp	28.4%-8.4pp	32.8%-6.7pp	34%-3.9pp
Free cash flow margin	18.8%-1.8pp	16.8%-6.7pp	15.7%-7.9pp	15.5%-9.5pp	20.6%-3.2pp
Returns
Return on assets	4.8%-4.0pp	6.1%-4.2pp	7%-3.3pp	8.7%-2.9pp	8.9%-4.3pp
Efficiency
Asset turnover	0.4×0.0×	0.4×0.0×	0.5×0.0×	0.5×0.0×	0.5×-0.1×
Inventory turnover	2.1×-0.3×	2.2×-0.6×	2.3×-0.5×	2.3×-0.5×	2.4×-0.4×
Liquidity
Current ratio	3.9×+0.9×	4×+0.9×	3.1×-0.3×	3.3×-0.2×	3×+0.8×
Quick ratio	2.8×+0.8×	2.9×+0.7×	2.2×-0.4×	2.2×-0.4×	2×+0.3×
Cash ratio	1×+0.1×	1.1×+0.2×	1.1×-0.2×	1.1×-0.3×	0.9×+0.1×
Leverage
Debt-to-assets	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×
Net debt / EBITDA	3×+1.1×	2.5×+0.5×	2.1×+0.5×	2×+0.4×	1.9×+0.2×
Interest coverage	4.5×-2.4×	5.5×-1.3×	5.9×-0.5×	7.1×+1.4×	6.9×+1.0×
Valuation
Market capitalization	$927.72M-19.9%	$1.23B-31.1%	$1.24B-47.9%	$1.16B-40.8%	$1.38B-34.6%
Enterprise value	$1.44B-11.3%	$1.72B-24.9%	$1.68B-40.3%	$1.63B-31.9%	$1.85B-27.1%
Price / earnings	11.7×+3.5×	12.5×+1.4×	11.1×-4.0×	8.6×-3.1×	9.8×-3.9×
Price / sales	1.3×-0.3×	1.7×-0.7×	1.7×-1.6×	1.6×-1.1×	1.9×-1.2×
EV / EBITDA	8.3×+1.7×	8.7×-0.1×	8.2×-2.4×	6.9×-1.6×	7.5×-2.5×
EV / sales	2×-0.2×	2.4×-0.7×	2.3×-1.6×	2.3×-1.1×	2.5×-1.2×
Free cash flow yield	14.6%+1.6pp	9.9%+0.2pp	9.1%+2.0pp	9.7%+0.6pp	10.9%+3.3pp
Earnings yield	8.5%-3.7pp	8%-1.0pp	9%+2.4pp	11.6%+3.1pp	10.3%+2.9pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Amphastar Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Amphastar Pharmaceuticals's profit margins?: Amphastar Pharmaceuticals (AMPH) runs a 47.3% gross margin and a 16.2% operating margin, with a 11.0% net margin.
Where do Amphastar Pharmaceuticals's ratios come from?: Every ratio is computed from Amphastar Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.